DHR
Danaher Corporation NYSE Listed Dec 29, 1978$177.17
-0.33%
vs $177.76
Mkt Cap $126.0B
52w Low $161.91
19.0% of range
52w High $242.05
50d MA $179.54
200d MA $204.22
P/E (TTM)
35.1x
EV/EBITDA
20.1x
P/B
2.4x
Debt/Equity
0.3x
ROE
7.0%
P/FCF
23.9x
RSI (14)
42.90
ATR (14)
$4.46
Beta
0.99
50d MA
$179.54
200d MA
$204.22
Avg Volume
4.5M
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automation, centrifugation, particle counting and characterization; microscopes; genomics consumables; and Gene and Cell Therapy. This segment also offers bioprocess technologies, consumables, and services; and filtration, separation, and purification technologies to the pharmaceutical and biopharmaceutical, food and beverage, medical, and life sciences companies, as well as universities, medical schools and research institutions, and various industrial manufacturers. The Diagnostics segment provides chemistry, immunoassay, microbiology, and automation systems, as well as hematology, molecular, acute care, and pathology diagnostics products. This segment offers clinical instruments, reagents, consumables, software, and services for hospitals, physicians' offices, reference laboratories, and other critical care settings. The Environmental & Applied Solutions segment offers instrumentation, consumables, software, services, and disinfection systems to analyze, treat, and manage ultra-pure, potable, industrial, waste, ground, source, and ocean water in residential, commercial, industrial, and natural resource applications. This segment also provides instruments, software, services, and consumables for various color and appearance management, packaging design and quality management, packaging converting, printing, marking, coding, and traceability applications for consumer, pharmaceutical, and industrial products. The company was formerly known as Diversified Mortgage Investors, Inc. and changed its name to Danaher Corporation in 1984. Danaher Corporation was founded in 1969 and is headquartered in Washington, the District of Columbia.
2200 Pennsylvania Avenue, NW · Washington, DC 20037-1701 · US
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 21, 2026 | AMC | 1.94 | 2.06 | +6.2% | 194.54 | -0.3% | -5.4% | -3.0% | -0.7% | +1.9% | -0.9% | — |
| Jan 28, 2026 | AMC | 2.16 | 2.23 | +3.2% | 224.54 | -0.5% | -2.2% | -0.3% | +2.1% | -3.1% | +1.4% | — |
| Oct 21, 2025 | AMC | 1.72 | 1.89 | +9.9% | 220.77 | +0.8% | -1.2% | +2.1% | +0.1% | -0.9% | -1.9% | — |
| Jul 22, 2025 | AMC | 1.64 | 1.80 | +9.8% | 189.91 | +5.6% | +4.2% | +2.5% | +1.3% | -1.2% | +1.9% | — |
| Apr 22, 2025 | AMC | 1.63 | 1.88 | +15.3% | 192.07 | +4.1% | +2.2% | +0.1% | +0.3% | -0.6% | +1.5% | — |
| Jan 29, 2025 | AMC | 2.14 | 2.14 | +0.0% | 223.73 | +0.6% | -0.3% | -0.2% | -3.8% | +0.3% | -1.3% | — |
| Oct 22, 2024 | AMC | 1.57 | 1.71 | +8.9% | 261.28 | -1.1% | -2.0% | -3.1% | -1.1% | -0.5% | -0.6% | — |
| Jul 23, 2024 | AMC | 1.57 | 1.72 | +9.6% | 264.18 | -0.9% | +0.6% | +1.6% | +1.4% | -0.8% | +1.3% | — |
| Apr 23, 2024 | AMC | 1.72 | 1.92 | +11.6% | 253.11 | -1.6% | -1.1% | -1.8% | +0.3% | +0.1% | -0.1% | — |
| Jan 30, 2024 | AMC | 1.90 | 2.09 | +10.0% | 244.95 | +0.3% | -2.1% | +2.2% | +0.5% | -0.2% | +1.0% | — |
| Oct 24, 2023 | AMC | 1.83 | 2.02 | +10.4% | 196.84 | -2.0% | -2.1% | +0.5% | -3.0% | -1.5% | +3.7% | — |
| Jul 25, 2023 | AMC | 2.00 | 2.05 | +2.5% | 226.65 | -0.5% | +3.6% | -3.6% | +1.9% | -1.9% | -0.0% | — |
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 11 | Piper Sandler | Initiates | Neutral | $200 | $183.63 | $182.49 | -0.6% | -1.5% | -0.4% | +0.6% | +0.1% | -2.0% |
| Jun 3 | DZ Bank | Initiates | Buy | $210 | $176.11 | $175.86 | -0.1% | +1.1% | +4.8% | -1.3% | -0.4% | +2.7% |
| Jun 2 | Wolfe Research | Reiterates | Peer Perform | — | $179.87 | $177.74 | -1.2% | -2.1% | +1.1% | +4.8% | -1.3% | -0.4% |
| May 26 | Citigroup | Reiterates | Buy | $230 | $172.00 | $171.17 | -0.5% | +0.5% | +0.2% | +4.3% | +1.1% | -1.5% |
| May 15 | RBC Capital Mkts | Reiterates | Outperform | $200 | $164.54 | $165.58 | +0.6% | -1.6% | +1.2% | +1.9% | +2.4% | +1.3% |
| Apr 23 | Morgan Stanley | Maintains | Overweight → Overweight | — | $184.04 | $180.82 | -1.7% | -3.0% | -0.7% | +1.9% | -0.9% | -0.1% |
| Apr 22 | UBS | Maintains | Buy → Buy | — | $194.54 | $193.95 | -0.3% | -5.4% | -3.0% | -0.7% | +1.9% | -0.9% |
| Apr 22 | Guggenheim | Maintains | Buy → Buy | — | $194.54 | $193.95 | -0.3% | -5.4% | -3.0% | -0.7% | +1.9% | -0.9% |
| Apr 22 | Wells Fargo | Maintains | Equal Weight → Equal Weight | — | $194.54 | $193.95 | -0.3% | -5.4% | -3.0% | -0.7% | +1.9% | -0.9% |
| Apr 22 | Baird | Maintains | Outperform → Outperform | — | $194.54 | $193.95 | -0.3% | -5.4% | -3.0% | -0.7% | +1.9% | -0.9% |
| Apr 17 | Baird | Maintains | Outperform → Outperform | — | $193.78 | $194.58 | +0.4% | +0.5% | +0.4% | -0.5% | -5.4% | -3.0% |
| Apr 14 | Barclays | Maintains | Overweight → Overweight | — | $195.87 | $195.62 | -0.1% | +1.4% | -0.2% | -2.2% | +0.5% | +0.4% |
| Apr 13 | Goldman Sachs | Maintains | Buy → Buy | — | $189.61 | $188.67 | -0.5% | +3.3% | +1.4% | -0.2% | -2.2% | +0.5% |
| Apr 6 | Evercore ISI | Maintains | Outperform → Outperform | — | $191.12 | $190.63 | -0.3% | +0.5% | -0.6% | +2.7% | -1.6% | -1.8% |
| Jan 29 | Jefferies | Maintains | Buy → Buy | — | $224.54 | $223.32 | -0.5% | -2.2% | -0.3% | +2.1% | -3.1% | +1.4% |
| Jan 29 | JP Morgan | Maintains | Overweight → Overweight | — | $224.54 | $223.32 | -0.5% | -2.2% | -0.3% | +2.1% | -3.1% | +1.4% |
| Jan 7 | TD Cowen | Maintains | Buy → Buy | — | $236.59 | $236.85 | +0.1% | -0.4% | -0.2% | +1.4% | +0.3% | -1.4% |
| Jan 5 | Guggenheim | Maintains | Buy → Buy | — | $230.40 | $229.28 | -0.5% | +2.2% | +0.5% | -0.4% | -0.2% | +1.4% |
| Dec 15 | Wells Fargo | Maintains | Equal Weight → Equal Weight | — | $226.33 | $227.85 | +0.7% | +1.0% | -1.7% | -0.9% | +0.8% | +0.2% |
| Oct 23 | Wells Fargo | Maintains | Equal Weight → Equal Weight | — | $218.10 | $217.60 | -0.2% | +2.1% | +0.1% | -0.9% | -1.9% | -1.3% |
| Oct 22 | Barclays | Maintains | Overweight → Overweight | — | $220.77 | $222.50 | +0.8% | -1.2% | +2.1% | +0.1% | -0.9% | -1.9% |
| Oct 22 | TD Cowen | Maintains | Buy → Buy | — | $220.77 | $222.50 | +0.8% | -1.2% | +2.1% | +0.1% | -0.9% | -1.9% |
| Oct 8 | Rothschild & Co | Downgrade | Buy → Neutral | — | $208.77 | $206.90 | -0.9% | -1.8% | -0.2% | -1.0% | +1.3% | +0.5% |
| Oct 7 | Evercore ISI | Maintains | Outperform → Outperform | — | $211.71 | $212.51 | +0.4% | -1.4% | -1.8% | -0.2% | -1.0% | +1.3% |
| Sep 22 | BofA Securities | Maintains | Buy → Buy | — | $193.29 | $191.90 | -0.7% | -1.5% | -0.4% | -2.0% | -2.4% | +1.9% |
| Jul 23 | Guggenheim | Maintains | Buy → Buy | — | $189.91 | $200.52 | +5.6% | +4.2% | +2.5% | +1.3% | -1.2% | +1.9% |
| Jul 23 | Wells Fargo | Maintains | Equal Weight → Equal Weight | — | $189.91 | $200.52 | +5.6% | +4.2% | +2.5% | +1.3% | -1.2% | +1.9% |
| Jul 23 | UBS | Maintains | Buy → Buy | — | $189.91 | $200.52 | +5.6% | +4.2% | +2.5% | +1.3% | -1.2% | +1.9% |
| Jul 23 | Baird | Maintains | Outperform → Outperform | — | $189.91 | $200.52 | +5.6% | +4.2% | +2.5% | +1.3% | -1.2% | +1.9% |
| Jul 18 | Baird | Maintains | Outperform → Outperform | — | $194.79 | $195.66 | +0.4% | -2.4% | -1.0% | +1.0% | +4.2% | +2.5% |
| Jul 11 | Scotiabank | Upgrade | Sector Perform → Sector Outperform | — | $205.51 | $205.51 | +0.0% | -0.3% | -3.5% | -2.5% | +0.2% | +0.8% |
| Jul 8 | Evercore ISI | Maintains | Outperform → Outperform | — | $199.63 | $199.18 | -0.2% | +0.5% | +0.1% | +2.3% | -0.3% | -3.5% |
| Jun 24 | Barclays | Maintains | Overweight → Overweight | — | $196.34 | $197.35 | +0.5% | +0.6% | +1.8% | +0.2% | -1.3% | -0.6% |
| Apr 23 | RBC Capital | Maintains | Outperform → Outperform | — | $192.07 | $200.02 | +4.1% | +2.2% | +0.1% | +0.3% | -0.6% | +1.5% |
| Apr 23 | Baird | Maintains | Outperform → Outperform | — | $192.07 | $200.02 | +4.1% | +2.2% | +0.1% | +0.3% | -0.6% | +1.5% |
| Apr 23 | UBS | Maintains | Buy → Buy | — | $192.07 | $200.02 | +4.1% | +2.2% | +0.1% | +0.3% | -0.6% | +1.5% |
| Apr 23 | Guggenheim | Maintains | Buy → Buy | — | $192.07 | $200.02 | +4.1% | +2.2% | +0.1% | +0.3% | -0.6% | +1.5% |
| Apr 23 | Goldman Sachs | Maintains | Buy → Buy | — | $192.07 | $200.02 | +4.1% | +2.2% | +0.1% | +0.3% | -0.6% | +1.5% |
| Apr 22 | JP Morgan | Maintains | Overweight → Overweight | — | $184.96 | $198.24 | +7.2% | +3.8% | +2.2% | +0.1% | +0.3% | -0.6% |
| Apr 22 | Jefferies | Maintains | Buy → Buy | — | $184.96 | $198.24 | +7.2% | +3.8% | +2.2% | +0.1% | +0.3% | -0.6% |
| Apr 22 | Barclays | Maintains | Overweight → Overweight | — | $184.96 | $198.24 | +7.2% | +3.8% | +2.2% | +0.1% | +0.3% | -0.6% |
| Apr 16 | Baird | Maintains | Outperform → Outperform | — | $189.92 | $192.46 | +1.3% | +0.4% | -2.0% | -1.0% | +3.8% | +2.2% |
| Apr 10 | Barclays | Upgrade | Equal Weight → Overweight | — | $191.89 | $192.45 | +0.3% | -5.8% | +4.4% | +2.2% | -1.6% | +0.4% |
| Mar 14 | Stifel | Upgrade | Hold → Buy | — | $204.09 | $206.13 | +1.0% | +3.3% | +0.9% | +0.1% | -1.2% | -0.0% |
| Feb 3 | Raymond James | Downgrade | Outperform → Market Perform | — | $222.74 | $218.00 | -2.1% | -3.8% | +0.3% | -1.3% | -1.0% | -1.5% |
| Jan 30 | Baird | Maintains | Outperform → Outperform | — | $223.73 | $225.00 | +0.6% | -0.3% | -0.2% | -3.8% | +0.3% | -1.3% |
| Jan 30 | RBC Capital | Maintains | Outperform → Outperform | — | $223.73 | $225.00 | +0.6% | -0.3% | -0.2% | -3.8% | +0.3% | -1.3% |
| Jan 30 | Barclays | Maintains | Equal Weight → Equal Weight | — | $223.73 | $225.00 | +0.6% | -0.3% | -0.2% | -3.8% | +0.3% | -1.3% |
| Jan 30 | Wells Fargo | Maintains | Equal Weight → Equal Weight | — | $223.73 | $225.00 | +0.6% | -0.3% | -0.2% | -3.8% | +0.3% | -1.3% |
| Jan 30 | Citigroup | Maintains | Buy → Buy | — | $223.73 | $225.00 | +0.6% | -0.3% | -0.2% | -3.8% | +0.3% | -1.3% |
| Date | Insider | Title | Type | Shares | Price | Value | Owned After | D1% | D5% |
|---|---|---|---|---|---|---|---|---|---|
| May 1, 2026 | SPOON ALAN GDir | — | Sell | 1,358 | $174.67 | $237K | 124,093 | +0.34% | -2.71% |
8-K · 2.01
!!! Very High
Masimo Corporation -- 8-K 2.01: Acquisition Completed
Jun 10
8-K · 8.01
!! High
Danaher Corporation -- 8-K 8.01: Material Event / Announcement
Jun 3
8-K
MiniMed Group, Inc. -- 8-K Filing
Medtronic appointed a seasoned executive from Danaher with extensive regulatory and quality expertise to lead its Engineering and Innovation Center, strengthening the company's product development capabilities.
May 18
8-K · 7.01
! Medium
Masimo Corporation -- 8-K 7.01: Regulation FD Disclosure
Masimo disclosed material information via press release that investors should review in Exhibit 99.1 for details on developments affecting the company and its parent Danaher.
May 4
8-K
Masimo Corporation -- 8-K Filing
Masimo faces three stockholder lawsuits challenging its merger with Danaher, filed after the definitive proxy statement was disclosed, potentially delaying or jeopardizing the transaction's completion.
Apr 23
8-K
Danaher Corporation -- 8-K Filing
Danaher reported Q1 2026 results from continuing operations, with year-over-year comparisons providing investors insight into the conglomerate's operational performance across its diversified portfolio.
Apr 21
— 8-K filing (BAC, BNPQF, DHR)
Apr 17
8-K · 1.01
! Medium
Danaher Corporation -- 8-K 1.01: Financing / Debt Agreement
Danaher secured a credit facility extending to April 2027 with a one-year extension option available upon 0.50% fee payment, providing financial flexibility for capital management.
Apr 17
8-K · 5.02
!!! Very High
Unknown — 8-K 5.02: Executive Change
An experienced life sciences executive is joining one of these companies, likely signaling leadership transition or strategic expansion in biotech/pharma sectors, which could impact growth direction and investor confidence.
Apr 7
8-K · 5.02
!!! Very High
Danaher Corporation -- 8-K 5.02: Executive Change
Danaher's appointment of a new executive signals potential strategic shifts in operations and governance; investors should monitor announcements regarding leadership responsibilities and company direction.
Feb 17
8-K
Danaher Corporation -- 8-K Filing
Danaher's 8-K disclosure likely addresses a material event—possibly an acquisition, dividend change, or executive transition—that could significantly impact earnings, cash flow, or strategic direction, warranting investor review.
Feb 10
Institutional (13F) — Top 20
All ↗
| # | Manager | Shares | Value | Chg | Period |
|---|---|---|---|---|---|
| 1 | Vanguard Capital Management Llc | 41,127,810 | $7.8B | New | Mar 2026 |
| 2 | Morgan Stanley | 21,289,124 | $4.9B | Reduced | Dec 2025 |
| 3 | Fmr Llc | 22,534,329 | $4.3B | Added | Mar 2026 |
| 4 | Jpmorgan Chase & Co | 16,917,649 | $3.1B | Reduced | Mar 2026 |
| 5 | Vanguard Portfolio Management Llc | 13,954,705 | $2.6B | New | Mar 2026 |
| 6 | Capital Research Global Investors | 8,897,773 | $1.7B | Added | Mar 2026 |
| 7 | Generation Investment Management Llp | 7,274,395 | $1.4B | Reduced | Mar 2026 |
| 8 | Northern Trust Corp | 7,080,901 | $1.3B | Reduced | Mar 2026 |
| 9 | Janus Henderson Group Plc | 6,489,965 | $1.2B | New | Mar 2026 |
| 10 | Bank Of America Corp /de/ | 6,252,116 | $1.2B | Reduced | Mar 2026 |
| 11 | Dz Bank Ag Deutsche Zentral Genossenschafts Bank, Frankfurt Am Main | 3,919,321 | $1.1B | Reduced | Sep 2024 |
| 12 | Nuveen, Llc | 5,334,755 | $1.0B | Reduced | Mar 2026 |
| 13 | Franklin Resources Inc | 4,566,512 | $866M | Reduced | Mar 2026 |
| 14 | Aristotle Capital Management, Llc | 3,705,139 | $848M | Reduced | Dec 2025 |
| 15 | Invesco Ltd. | 4,021,153 | $762M | Reduced | Mar 2026 |
| 16 | Flossbach Von Storch Se | 3,995,873 | $758M | Reduced | Mar 2026 |
| 17 | Parnassus Investments, Llc | 3,974,829 | $754M | Reduced | Mar 2026 |
| 18 | Bank Of New York Mellon Corp | 3,828,208 | $726M | Reduced | Mar 2026 |
| 19 | Arrowstreet Capital, Limited Partnership | 3,639,630 | $690M | — | Mar 2026 |
| 20 | Principal Financial Group Inc | 2,928,406 | $670M | Reduced | Dec 2025 |
Mutual Funds / ETFs (N-PORT) — Top 20
All ↗
Valuation
Market Cap
$125.97B
Enterprise Value
$139.77B
P/E (TTM)
35.15x
Forward P/E
21.00x
PEG Ratio
-9.18x
P/B
2.39x
P/S
5.13x
P/FCF
23.95x
EV/EBITDA
20.13x
Shares Out
711.0M
Financials (TTM)
Revenue
$24.57B
Net Income
$3.61B
EBITDA
$6.95B
Free Cash Flow
$5.26B
Op Cash Flow
$6.42B
EPS Basic
$5.07
EPS Diluted
$5.04
EPS Forward
$8.44
Gross Margin
60.9%
Op Margin
20.9%
Net Margin
14.7%
Balance Sheet
Total Assets
$83.46B
Total Liab.
$30.93B
Total Equity
$52.54B
Cash
$4.62B
LT Debt
$18.42B
Book Value/Sh
$74.27
Debt/Equity
0.35x
Current Ratio
1.87
Quick Ratio
1.51
Returns & Growth
ROE
7.0%
ROA
4.4%
ROIC
5.7%
Rev Growth YoY
+2.9%
EPS Growth YoY
-4.9%
Price Returns
2W
+11.0%
1M
+2.1%
3M
-13.3%
6M
-19.5%
12M
-3.8%
Technicals
52W High
$242.05
52W Low
$161.91
50d MA
$179.54
200d MA
$204.22
RSI (14)
42.90
ATR (14)
$4.46
Beta
0.99
Avg Volume
4.5M
Dividends
Div Rate
$1.24
Div Yield
0.7%
Frequency
4
Ex-Div Date
Mar 27, 2026
Analyst Price Targets
Consensus
$247.00
High
$270.00
Low
$205.00
Median
$249.00
Data updated apr 25, 2026 5:10am
· Source: financialmodelingprep.com